市場調查報告書

癌症生物標記的全球市場:各生物標記的類型、分析技術、癌症的類型、用途、地區 - 分析與2027年為止的預測

Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type ; Profiling Technology ; Cancer Type ; Application and Geography

出版商 The Insight Partners 商品編碼 916873
出版日期 內容資訊 英文 241 Pages
訂單完成後即時交付
價格
Back to Top
癌症生物標記的全球市場:各生物標記的類型、分析技術、癌症的類型、用途、地區 - 分析與2027年為止的預測 Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type ; Profiling Technology ; Cancer Type ; Application and Geography
出版日期: 2019年10月16日內容資訊: 英文 241 Pages
簡介

全球癌症生物標記市場在2018年估算為的121記憶7,569萬美金。該市場在2019年∼2027年間,預測將以11.1%的年複合成長率成長,2027年達到312記憶600萬美元的規模。

本報告提供全球癌症生物標記市場的相關調查,市場機會和趨勢,成長及阻礙因素,各生物標記的類型、分析技術、癌症的類型、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查範圍
  • The Insight Partners調查報告概要
  • 市場區隔

第2章 要點

第3章 調查方法

  • 調查範圍
  • 二次調查
  • 一次調查

第4章 市場預測

  • 概要
  • PEST分析

第5章 主要產業動態

  • 主要市場成長要素
    • 全球癌症的罹患率增加
    • 新產品的銷售及FDA的認證
    • 技術的進步
  • 主要市場阻礙因素
    • 不利的法規及償付方案
  • 主要市場機會
    • 新興國家的市場
  • 今後趨勢
    • 對個人化醫療的意向
  • 影響分析

第6章 全球市場分析

  • 市場收益預測與分析
  • 市場預測及分析:各地區
  • 主要企業的成果

第7章 市場分析:生物標記的各類型

  • 概要
  • 市場佔有率
  • 遺傳的生物標記
  • 蛋白質生物標記
  • 其他

第8章 市場分析:各分析技術

  • 概要
  • 市場佔有率
  • OMICS技術
  • 成像技術
  • 免疫測量
  • 細胞遺傳學
  • 生物資訊學

第9章 市場分析:癌症的各類型

  • 概要
  • 市場佔有率
  • 乳癌
  • 肺癌
  • 前列腺癌
  • 白血病
  • 膀胱癌
  • 其他

第10章 市場分析:各用途

  • 概要
  • 市場佔有率
  • 診斷
  • 研究開發
  • 預後前兆
  • 其他

第11章 市場分析:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第12章 競爭情形

  • 概要
  • 市場參與企業所進行的成長策略
  • 有機的開發
  • 無機的開發

第13章 企業簡介

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Hologic Inc.
  • Quest Diagnostics Incorporated
  • BioMerieux SA
  • Creative Diagnostics

章14章 附錄

  • 關於The Insight Partners
  • 詞彙表
目錄
Product Code: TIPBT00002663

The global cancer biomarkers market is expected to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.

Driving factors such as growing cancer prevalence across the globe, new product launches and FDA approvals, and technological advancements are expected to boost the market over the years. However unfavorable regulatory and reimbursement scenario is likely to have a negative impact on the growth of the market in the coming years. Besides, the development opportunities in emerging countries are likely to have a positive effect on the growth of the market in the forecast years.

Cancer immunotherapies are rapidly replacing traditional treatment standards and expanding the therapeutic landscape for cancer patients. Researchers are focused on finding molecules in the blood that can signal the appearance of cancers. For the diagnosis of ovarian and prostate cancers, the cancer antigen (CA)125 and prostate-specific antigen (PSA) are used alongside other tests. Additionally, advancements in high-throughput omics technologies, including genomics, proteomics, transcriptomics, and metabolomics, has accelerated the pace of biomarker discovery.

The emerging markets like the Asia Pacific are creating better opportunities for significant market players to expand their business. This is a prime reason for market growth in the forecast period. Most of the major players focus on emerging countries such as India, China, and others owing to a large number of cancer patients and growing medical tourism in developing countries. Most of the emerging countries are preferred place for medical tourism. As per the Australian Institute of Health and Welfare, 140,000 new cases of cancer are diagnosed in 2018 and the low cost of surgeries, advanced technologies with less waiting time for procedures in the region is likely to boost the demand for cancer biomarkers

In 2018, the breast cancer segment accounted for the largest market share in the global cancer biomarkers market by the cancer type segment. The biological features of the tumor used for estimating diagnosis and select suitable therapy for patients with breast cancer. HER2 is a growth factor receptor present on the surface of breast cells. Approximately 30% of breast cancer patients have tumors, which expresses a large amount of HER2. Various anti-cancer drugs are targeted for protein, making an accurate determination of the presence or absence of the protein in a tumor a vital step in calculating the proper treatment. At present, the cases of cancer are increasing across the globe.

The global cancer biomarkers market is segmented by biomarker type, profiling technology, cancer type, application, and end-user. On the basis of product, the market is segmented into antibodies, equipment, reagents, and kits. On the basis of cancer type, the market is segmented into breast cancer, lung cancer, prostate cancer, leukemia, bladder cancer, and other cancer types. Based on application, the market is segmented into diagnostics, research and development, prognostics, and other applications. On the basis of biomarker type, the market is segmented into genetic biomarkers, protein biomarkers and other cancer biomarkers. On the basis of profiling technology, the market is segmented into omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics.

Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Cancer Association of South Africa (CANSA), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR),

Reasons to Buy

Save and reduce time carrying out entrylevel research by identifying the growth, size, leading players and segments in the cancer biomarkers market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global cancer biomarkers market, thereby allowing players across the value chain to develop effective longterm strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize indepth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decisionmaking process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cancer Biomarkers Market - By Biomarker Type
    • 1.3.2 Global Cancer Biomarkers Market - By Profiling Technology
    • 1.3.3 Global Cancer biomarkers Market - By Cancer Type
    • 1.3.4 Global Cancer biomarkers Market - By Application
    • 1.3.5 Global Cancer biomarkers Market - By Geography

2. Global Cancer biomarkers Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cancer biomarkers Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Cancer Biomarkers Market - North America PEST Analysis
    • 4.2.2 Cancer Biomarkers Market - Europe PEST Analysis
    • 4.2.3 Cancer Biomarkers Market - Asia Pacific PEST Analysis
    • 4.2.4 Cancer Biomarkers Market - Middle East & Africa PEST Analysis
    • 4.2.5 Cancer Biomarkers Market - South and Central America PEST Analysis

5. Global Cancer Biomarkers Market - Key Industry Dynamics

    • 5.1.1 Growing Cancer Prevalence Across The Globe
    • 5.1.2 New Product Launches & FDA Approvals
    • 5.1.3 Technological Advancements
  • 5.2 Key Market Restraints
    • 5.2.1 Unfavourable Regulatory and Reimbursement Scenario
  • 5.3 Key Market Opportunities
    • 5.3.1 Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Inclination Towards Personalized Medicine
  • 5.5 Impact Analysis

6. Cancer biomarkers Market - Global Analysis

  • 6.1 Global Cancer biomarkers Market Revenue Forecasts And Analysis
  • 6.2 Global Cancer biomarkers Market, By Geography - Forecasts And Analysis
  • 6.3 Performance of Key Players

7. Cancer biomarkers Market Revenue And Forecasts To 2027 - Biomarker Type

  • 7.1 Overview
  • 7.2 Global Cancer Biomarkers Market Share by Biomarker Type 2018 & 2027 (%)
  • 7.3 Genetic Biomarkers
    • 7.3.1 Overview
    • 7.3.2 Genetic Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Protein Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Protein Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Other Cancer Biomarkers
    • 7.5.1 Overview
    • 7.5.2 Other Cancer Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)

8. Cancer Biomarkers Market Analysis And Forecasts To 2027 - Profiling Technology

  • 8.1 Overview
  • 8.2 Global Cancer Biomarkers Market Share by Profiling Technology 2018 & 2027 (%)
  • 8.3 Omics Technologies
    • 8.3.1 Overview
    • 8.3.2 Omics Technologies Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Imaging Technologies
    • 8.4.1 Overview
    • 8.4.2 Imaging Technologies Market Revenue and Forecast to 2027 (US$ Mn)
    • 8.4.3 Ultrasound
      • 8.4.3.1 Overview
      • 8.4.3.2 Ultrasound Market Revenue and Forecast to 2027 (US$ Mn)
    • 8.4.4 Computed Tomography (CT)
      • 8.4.4.1 Overview
      • 8.4.4.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
    • 8.4.5 Magnetic Resonance Imaging (MRI)
      • 8.4.5.1 Overview
      • 8.4.5.2 Global Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2027 (US$ Mn)
    • 8.4.6 Positron Emission Tomography (PET) Market
      • 8.4.6.1 Overview
      • 8.4.6.2 Global Positron Emission Tomography (PET) Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Immunoassays
      • 8.5.1.1 Overview
      • 8.5.1.2 Immunoassays Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.6 Cytogenetics
    • 8.6.1 Overview
    • 8.6.2 Cytogenetics Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.7 Bioinformatics
    • 8.7.1 Overview
    • 8.7.2 Bioinformatics Market Revenue and Forecast to 2027 (US$ Mn)

9. Global Cancer biomarkers Market Revenue And Forecasts To 2027 - by Cancer Type

  • 9.1 Overview
  • 9.2 Global Cancer Biomarkers Market, By Cancer Type 2018 & 2027 (%)
  • 9.3 Breast Cancer Market
    • 9.3.1 Overview
    • 9.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.4 Lung Cancer Market
    • 9.4.1 Overview
    • 9.4.2 Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.5 Prostate Cancer Market
    • 9.5.1 Overview
    • 9.5.2 Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.6 Leukemia Market
    • 9.6.1 Overview
    • 9.6.2 Global Leukemia Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.7 Bladder Cancer Market
    • 9.7.1 Overview
    • 9.7.2 Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.8 Other Cancer Market
    • 9.8.1 Overview
    • 9.8.2 Global Other Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

10. Global Cancer biomarkers Market Revenue And Forecasts To 2027 - by Application

  • 10.1 Overview
  • 10.2 Global Cancer Biomarkers Market, By Application 2018 & 2027 (%)
  • 10.3 Diagnostics Market
    • 10.3.1 Overview
    • 10.3.2 Global Diagnostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.4 Research and Development Market
    • 10.4.1 Overview
    • 10.4.2 Global Research and Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.5 Prognostics Market
    • 10.5.1 Overview
    • 10.5.2 Global Prognostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.6 Others Market
    • 10.6.1 Overview
    • 10.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

11. Cancer Biomarkers Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 11.1 North America Cancer Biomarkers Market Revenue And Forecasts To 2027
    • 11.1.1 North America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.1.2 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.1.3 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.1.3.1 North America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.1.4 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.1.5 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.1.6 North America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
    • 11.1.7 US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.7.1 US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.7.2 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.1.7.3 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.1.7.3.1 US Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.1.7.4 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.1.7.5 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.1.8 Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.8.1 Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.8.2 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.1.8.3 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.1.8.3.1 Canada Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.1.8.4 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.1.8.5 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.1.9 Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.9.1 Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.1.9.2 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.1.9.3 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.1.9.3.1 Mexico Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.1.9.4 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.1.9.5 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 11.2 Europe Cancer Biomarkers Market Revenue And Forecasts To 2027
    • 11.2.1 Europe Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.2.2 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.2.3 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.2.3.1 Europe Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.2.4 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.2.5 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.2.6 Europe Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
    • 11.2.7 UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.7.1 UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.7.2 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.2.7.3 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.2.7.3.1 UK Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.2.7.4 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.2.7.5 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.2.8 Germany Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.8.1 Germany Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.8.2 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.2.8.3 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.2.8.3.1 Germany Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.2.8.4 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.2.8.5 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.2.9 France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.9.1 France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.9.2 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.2.9.3 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.2.9.3.1 France Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.2.9.4 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.2.9.5 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.2.10 Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.10.1 Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.10.2 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.2.10.3 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.2.10.3.1 Italy Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.2.10.4 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.2.10.5 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.2.11 Spain Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.11.1 Spain Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.2.11.2 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.2.11.3 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.2.11.3.1 Spain Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.2.11.4 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.2.11.5 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 11.3 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts To 2027
  • 11.4 Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.4.1 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.4.2 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.4.2.1 Asia Pacific Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.4.3 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.4.4 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.4.5 Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
    • 11.4.6 Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.6.1 Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.6.2 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.4.6.3 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.4.6.3.1 Japan Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.4.6.4 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.4.6.5 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.4.7 China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.7.1 China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.7.2 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.4.7.3 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.4.7.3.1 China Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.4.7.4 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.4.7.5 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.4.8 India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.8.1 India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.8.2 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.4.8.3 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.4.8.3.1 India Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.4.8.4 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.4.8.5 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.4.9 South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.9.1 South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.9.2 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.4.9.3 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.4.9.3.1 South Korea Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.4.9.4 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.4.9.5 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.4.10 Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.10.1 Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.4.10.2 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
      • 11.4.10.3 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
        • 11.4.10.3.1 Australia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 11.4.10.4 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
      • 11.4.10.5 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 11.5 Middle East & Africa Cancer biomarkers Market Revenue And Forecasts To 2027
    • 11.5.1 Middle East & Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.5.2 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.5.3 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.5.3.1 Middle East & Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.5.4 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.5.5 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.5.6 Middle East & Africa Cancer biomarkers Market Revenue and Forecasts to 2027, By Country (%)
    • 11.5.7 UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.5.7.1 UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.5.8 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.5.9 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.5.9.1 UAE Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.5.10 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.5.11 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.5.12 Saudi Arabia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.5.12.1 Saudi Arabia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.5.13 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.5.14 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.5.14.1 Saudi Arabia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.5.15 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.5.16 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.5.17 South Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.5.17.1 South Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.5.18 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.5.19 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.5.19.1 South Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.5.20 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.5.21 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • 11.6 South And Central America Cancer Biomarkers Market Revenue And Forecasts To 2027
    • 11.6.1 South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.6.2 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.6.3 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.6.3.1 South and Central America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.6.4 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.6.5 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.6.6 South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
    • 11.6.7 Argentina Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.6.7.1 Argentina Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.6.8 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.6.9 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.6.9.1 Argentina Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.6.10 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.6.11 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 11.6.12 Brazil Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 11.6.12.1 Brazil Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 11.6.13 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
    • 11.6.14 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
      • 11.6.14.1 Brazil Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 11.6.15 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
    • 11.6.16 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)

12. Cancer Biomarkers Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies done by the companies in the Market, 2018 (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic developments
    • 12.4.1 Overview

13. Cancer biomarkers Market-Key Company Profiles

  • 13.1 Bio-Rad Laboratories, Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Financial Information
    • 13.1.4 Product Portfolio
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific, Inc.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Financial Information
    • 13.2.4 Product Portfolio
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 F. Hoffmann-La Roche Ltd.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Financial Overview
    • 13.3.4 Product Portfolio
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.5 Qiagen N.V.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Financial Overview
    • 13.5.4 Product Portfolio
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.7 Illumina, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Financial Overview
    • 13.7.4 Product Portfolio
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Myriad Genetics, Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Financial Overview
    • 13.8.4 Product Portfolio
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Hologic Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Financial Overview
    • 13.9.4 Product Portfolio
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Quest Diagnostics Incorporated
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Overview
    • 13.10.4 Product Portfolio
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 BioMerieux SA
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Financial Information
    • 13.11.4 Product Portfolio
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Creative Diagnostics
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Financial Overview
    • 13.12.4 Product Portfolio
    • 13.12.5 SWOT ANALYSIS
    • 13.12.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 2. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 3. North America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 4. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 5. North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 6. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 7. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 8. US Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 9. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 10. US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 11. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 12. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 13. Canada Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 14. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 15. Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 16. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 17. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 18. Mexico Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 19. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 20. Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 21. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 22. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 23. Europe Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 24. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 25. Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 26. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 27. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 28. UK Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 29. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 30. UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 31. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 32. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 33. Germany Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 34. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 35. Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 36. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 37. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 38. France Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 39. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 40. France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 41. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 42. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 43. Italy Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 44. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 45. Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 46. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 47. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 48. Spain Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 49. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 50. Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 51. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 52. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 53. Asia Pacific Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 54. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 55. Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 56. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 57. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 58. Japan Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 59. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 60. Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 61. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 62. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 63. China Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 64. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 65. China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 66. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 67. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 68. India Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 69. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 70. India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 71. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 72. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 73. South Korea Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 74. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 75. South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 76. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 77. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 78. Australia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 79. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 80. Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 81. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 82. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 83. Middle East & Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 84. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 85. Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 86. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 87. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 88. UAE Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 89. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 90. UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 91. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 92. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 93. Saudi Arabia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 94. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 95. Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 96. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 97. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 98. South Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 99. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 100. South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 101. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 102. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 103. South and Central America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 104. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 105. South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 106. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 107. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 108. Argentina Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 109. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 110. Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 111. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
  • Table 112. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
  • Table 113. Brazil Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • Table 114. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
  • Table 115. Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
  • Table 116. Organic Developments Done By Companies
  • Table 117. Inorganic developments done by Companies
  • Table 118. Glossary of Terms, Cancer biomarkers Market

LIST OF FIGURES

  • Figure 1. Cancer Biomarkers Market Segmentation
  • Figure 2. Cancer Biomarkers Market Segmentation, by Region
  • Figure 3. Global Cancer biomarkers Market Overview
  • Figure 4. Protein Biomarker Segment Held Largest Share Of The Biomarker Type Segment In Cancer biomarkers Market
  • Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 6. Global Cancer biomarkers Market, By Geography (US$ Mn)
  • Figure 7. Global Cancer Biomarkers Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Cancer biomarkers Market, Industry Landscape
  • Figure 9. Cancer Biomarkers Market - North America PEST Analysis
  • Figure 10. Cancer Biomarkers Market - Europe Pest Analysis
  • Figure 11. Cancer Biomarkers Market - Asia Pacific Pest Analysis
  • Figure 12. Cancer Biomarkers Market - Middle East & Africa Pest Analysis
  • Figure 13. Cancer Biomarkers Market - South and Central America PEST Analysis
  • Figure 14. Most Prevalent Forms of Cancers Globally, 2018
  • Figure 15. Cancer Biomarkers Market Impact Analysis of Driver and Restraints
  • Figure 16. Global Cancer biomarkers Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 17. Global Cancer biomarkers Market - by Geography Forecasts and Analysis - 2018- 2027
  • Figure 18. Prominent Players in the Cancer biomarkers Market
  • Figure 19. Global Cancer Biomarkers Market Share by Biomarker Type 2018 & 2027 (%)
  • Figure 20. Genetic Biomarkers Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 21. Protein Biomarkers Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 22. Other Cancer Biomarkers Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 23. Global Cancer Biomarkers Market Share by Profiling Technology 2018 & 2027 (%)
  • Figure 24. Omics Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 25. Imaging Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 26. Ultrasound Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 27. Computed Tomography (CT)Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 28. Global Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Global Positron Emission Tomography (PET) Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 30. Immunoassays Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 31. Cytogenetics Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 32. Bioinformatics Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 33. Global Cancer Biomarkers Market, by Cancer Type 2018 & 2027 (%)
  • Figure 34. Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 36. Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Global Leukemia Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. Global Other Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 40. Global Cancer Biomarkers Market, by Application 2018 & 2027 (%)
  • Figure 41. Global Diagnostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 42. Global Research and Development Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Global Prognostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 44. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. North America Cancer Biomarkers Market Revenue Overview, by Country (2018) (US$ Mn)
  • Figure 46. North America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. North America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 48. US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 50. Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Europe Cancer Biomarkers Market Overview, by Country (2018)
  • Figure 52. Europe Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 53. Europe Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 54. UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 55. Germany Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 56. France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 57. Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 58. Spain Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 59. Asia Pacific Cancer Biomarkers Market Overview, by Country (2018)
  • Figure 60. Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 61. Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 62. Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 63. China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 64. India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 65. South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 66. Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 67. Middle East & Africa Cancer biomarkers Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 68. Middle East & Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 69. Middle East & Africa Cancer biomarkers Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 70. UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 71. Saudi Arabia Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 72. South Africa Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 73. South and Central America Cancer Biomarkers Market Revenue Overview, by Country, 2018 (US$ Mn)
  • Figure 74. South and Central America Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 75. South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 76. Argentina Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 77. Brazil Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 78. Growth Strategies done by the companies in the Market, 2018 (%)
Back to Top